Is methotrexate effective for the treatment of ankylosing spondylitis? Commentary

Nature Clinical Practice Rheumatology

Volumn 3, Issue 9, 2007, Pages 490-491

  Chen, Junmin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR DERIVATIVE; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED MEDICINE; HUMAN; LOW DRUG DOSE; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SHORT SURVEY; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 34548393254     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0566     Document Type: Short Survey

References (4)

1. Biasi D et al. (2000) Efficacy of methotrexate in the treatment of ankylosing spondylitis: A three-year open study. Clin Rheumatol 19: 114-117
2. Creemers MC et al. (1995) Methotrexate in severe ankylosing spondylitis: An open study. J Rheumatol 22: 1104-1107
3. Chen J et al. Methotrexate for ankylosing spondylitis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD004524.pub3. DOI: 10.1002/14651858.CD004524.pub3
4. Gonzalez-Lopez L et al. (2004) Efficacy of methotrexate in ankylosing spondylitis: A randomized, double blind, placebo controlled trial. J Rheumatol 31: 1568-1574